Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Atrial Fibrillation
Interventions
DRUG

Rivaroxaban

"Those in the non-interrupted anticoagulation group, anticoagulation is continued regardless of atrial fibrillation recurrence.~Those in the pill-in-the POCKET anticoagulation group will receive direct oral anticoagulation only if they have atrial fibrillation recur over 6 hours."

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

collaborator

Medtronic Korea Co., Ltd.

UNKNOWN

lead

Seoul National University Hospital

OTHER